Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OPX Biotechnologies
Boulder, Colorado, USA
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
OPX Biotechnologies was a synthetic biology company that developed a proprietary technology platform called EDGE (Efficiency Directed Genome Engineering) to produce renewable chemicals. The company's primary focus was the production of bio-acrylic acid, a key component in paints, coatings, and diapers, using microbial fermentation of sugar. By optimizing microbial metabolism, OPX aimed to provide cost-competitive and sustainable alternatives to petroleum-derived products. In 2015, the company's assets and intellectual property were acquired by Cargill, which integrated the technology into its bio-industrial business.
- Therapeutic areas
- Other
- Modalities
- Microbial fermentationSynthetic biology
- Industry
- Non-Drug Biotech
02
Partnerships
CargillDow ChemicalEvonik IndustriesNational Renewable Energy Laboratory (NREL)
Beyond the preview
Go deeper on OPX Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OPX Biotechnologies.